FOR IMMEDIATE RELEASE
Neurologists and Neuroscientists Will Gather to Shape the Future of Academic Neurology
American Neurological Association will host annual meeting—
October 12-14 in Baltimore, MD
MT. LAUREL, N.J., September 3, 2014 – Leading academic neurologists and neuroscientists from across the globe are expected to attend the 139th Association (ANA), to be held in Baltimore, MD, October 12-14, 2014.
Attendees of the upcoming meeting will hear from experts in the field, as they share the latest advances in neurologic research through interactive workshops, more than 40 scientific sessions, and more than 400 abstract presentations on the most timely, transformational advances in all areas of neurologic research.
“The ANA continues to evolve to meet the needs of the ever-changing academic neurology community,” said Sam Pleasure, M.D., Ph.D., chair of the Scientific Program Advisory Committee of the ANA. “This year’s program will have something for everyone—with topics of interest to our more senior-level members, to sessions geared towards junior faculty who are seeking career development guidance.”
Highlights of this year’s meeting include a keynote address on synaptic physiology by Dr. Thomas Südhof, Avram Goldstein Professor at the Stanford University School of Medicine, Investigator at the Howard Hughes Medical Institute and recipient of the 2013 Nobel Prize in Physiology or Medicine. Additionally, results from clinical trials in C9ORF72 ALS/FTD and the role of Gepants in migraines will be unveiled.
Throughout the event, attendees will have the opportunity to participate in special interest group sub-meetings, focusing on various topics including autoimmune neurology, behavioral neurology, cerebrovascular disease, multiple sclerosis, movement disorders, dementia and aging, headache and pain, neuromuscular disease, plus much more.
Other highlights include:
• Diseases of the Synapse; highlighting the latest data in synapse biology and understanding the role of synaptic dysfunction in diseases such as autism, Alzheimer’s disease, and schizophrenia.
• Derek Denny-Brown Young Neurological Scholar Symposium, featuring early- to mid-career neurologists and neuroscientists who have made outstanding basic and clinical scientific advances toward the prevention, diagnosis, treatment, and cure of neurological diseases.
• Presidential Symposium, focusing on the expanding roles of repeat mutations in ALS and related diseases and potential treatments to address this pathophysiology.
• Decoding for neurologists new NIH initiatives to understand and fund research in brain disease - the BRAIN Initiative and Connectome projects.
• Novel Concepts in Pain Generation and Treatment will discuss important basic concepts changing the understanding of neuropathic pain.
• Neurological Challenges Posed by Recurring and New Viral Infections will discuss the roles of established viruses in causing chronic neurologic disease as well as efforts designed to identify new emerging infections of the nervous system.
About the American Neurological Association
Founded in 1874, the American Neurological Association, is the premier professional society of academic neurologists and neuroscientists devoted to advancing the goals of academic neurology; to training and educating neurologists and other physicians in the neurologic sciences; and to expanding both our understanding of diseases of the nervous system of our ability to treat them. For more information, visit www.myana.org.